Clinical trial
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
- Lead sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 15, 2025
- Completion date
- February 15, 2029
- Enrollment
- 302 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, colorectal cancer, nsclc, oligometastatic disease, prostate cancer